Summary & Overview

CPT 86318: Single-Step Immunoassay for Antibody Detection

CPT code 86318 denotes a single-step immunoassay used to qualitatively or semiquantitatively detect antibodies in a patient specimen, most commonly blood. This laboratory procedure is widely used in infectious disease screening, serologic surveillance, and initial immune response assessment, making it relevant to public health monitoring and outpatient and inpatient diagnostic workflows nationwide. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, typical sites of service, and common billing considerations. The publication also summarizes available payer coverage patterns, common modifiers in use, and related billing considerations to aid coding accuracy and claims submission. Where specific payer policies or payment benchmarks exist, those are noted; if payer-specific data are unavailable, the report states that data are not available in the input. The content is intended to inform healthcare administrators, laboratory managers, and billing professionals about the clinical role of CPT code 86318, typical operational settings, and the topics to investigate further for payer-specific reimbursement and compliance guidance.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare86318CPTimmunoassaylaboratoryantibody-testingserologydiagnostic-testingclinical-lab

Billing Code Overview

CPT code 86318 describes a single-step immunoassay performed by a laboratory analyst to qualitatively or semiquantitatively detect antibodies in a patient specimen, such as blood, directed at an unspecified infectious agent. The procedure evaluates the presence or approximate concentration of antibodies to inform clinical interpretation of immune response or exposure.

Service type: Laboratory — immunoassay, single-step, qualitative/semiquantitative

Typical site of service: Clinical laboratory or hospital laboratory setting, where blood or other patient specimens are collected and analyzed using immunoassay platforms.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult presenting to an outpatient clinic or urgent care with recent symptoms suggestive of an acute infectious exposure (for example, fever, sore throat, malaise, or recent high‑risk contact). The clinician orders a single‑step immunoassay to qualitatively or semiquantitatively detect antibodies in the patient’s blood specimen to an unspecified infectious agent when a rapid screening for serologic response is appropriate. The workflow: the phlebotomist collects a blood sample (venous or capillary) and sends it to the laboratory; the lab analyst performs a single‑step immunoassay procedure and documents results as reactive/nonreactive or with semiquantitative signal; the laboratory results are reported back to the ordering clinician who interprets the finding in the clinical context and determines further testing or management (confirmatory testing, treatment decisions, or public health reporting). Typical sites of service include hospital outpatient laboratories, independent clinical laboratories, urgent care centers, and physician office laboratories. Patient scenarios include screening after suspected exposure, evaluation of a symptomatic patient when rapid serologic screening is indicated, or part of a panel of tests during an infectious disease workup.

Coding Specifications

Modifier	Description	When to Use
`00`	Default/No modifier	Use when no specific modifier applies to the service.
`11`	Office or other outpatient service (physician level)	Use when the professional component is reported and the service is part of a physician/clinical encounter context.
`26`	Professional component	Use when billing only the professional interpretation or consultative portion of a test when split billing of technical and professional components occurs.
`TC`	Technical component	Use when billing only the technical portion (laboratory performance, equipment, supplies) of the test.
`59`	Distinct procedural service	Use when the immunoassay is performed on the same date as another distinct service that is not usually reported together.
`90`	Reference (outside) laboratory	Use when the performing laboratory is an outside reference lab and billing must reflect referral testing.
`91`	Repeat clinical diagnostic laboratory test	Use when the same test is repeated on the same day for clinical reasons and repeat billing policy allows.
`52`	Reduced services	Use when the laboratory performed a reduced portion of the service compared with the full procedure.
`53`	Discontinued procedure	Use if the specimen or testing was begun but discontinued for clinical reasons prior to completion.
`22`	Increased procedural services	Use when work required to perform the test is substantially greater than typically required and payer policy allows use of modifier `22`.

Taxonomy Code	Specialty	Notes
294N00000X	Pathology & Laboratory Medicine	Laboratory directors and pathologists who oversee immunoassay testing and interpretation.
363A00000X	Clinical Laboratory	Clinical laboratory technicians and technologists performing the assay.
207Q00000X	Infectious Disease	Infectious disease physicians ordering and interpreting serologic testing.
207L00000X	Allergy & Immunology	Specialists who may order antibody testing as part of immune evaluation.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`R50.9`	Fever, unspecified	Common presenting symptom prompting serologic screening for infectious causes.
`R05`	Cough	Respiratory symptom that may prompt infectious disease serologic evaluation in certain contexts.
`R07.9`	Chest pain, unspecified	Symptom that can be part of systemic infection evaluation when serology is considered.
`B34.9`	Viral infection, unspecified	General diagnostic category for which antibody screening may be ordered when specific etiology is not yet identified.
`Z20.9`	Contact with and (suspected) exposure to unspecified communicable disease	Common reason to perform antibody screening after known exposure.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Specimen collection commonly performed prior to immunoassay testing.
`81002`	Urinalysis, nonautomated, without microscopy (single test)	Ancillary specimen test sometimes ordered in the same visit for infectious workup; example of another point‑of‑care or CLIA‑waived test performed alongside serology.
`86580`	Skin test, tuberculosis, intradermal	Example of additional infectious disease screening tests ordered in the same evaluation; not a direct substitute but commonly paired in exposure assessments.
`86703`	Antibody; HIV-1/2, single result rapid test	A specific single‑step immunoassay for HIV antibodies commonly used in similar rapid serologic testing workflows.
`86318`	Single-step immunoassay for antibodies to an unspecified infectious agent	The subject procedure; used for rapid qualitative or semiquantitative antibody screening.